| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 03/03/2011 | US20110052578 Compounds and Compositions as Protein Kinase Inhibitors |
| 03/03/2011 | US20110052552 Compositions to effect neuronal growth |
| 03/03/2011 | US20110049495 Quinoxaline derivatives and organic light-emitting diodes comprising the same |
| 03/03/2011 | US20110049488 Heterocyclic compound and organic light-emitting device including the same |
| 03/03/2011 | CA2772164A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | CA2771936A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators |
| 03/03/2011 | CA2771775A1 Compounds and compositions as protein kinase inhibitors |
| 03/03/2011 | CA2770866A1 Cannabinoid receptor modulators |
| 03/03/2011 | CA2770475A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | CA2767770A1 Pyrrolidine derivatives as nk3 receptor antagonists |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289891A2 Novel polyquinoline derivates and the therapeutic use thereof |
| 03/02/2011 | EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 03/02/2011 | EP2289877A1 Organic light emitting device containing polycyclic heteroaryl compounds |
| 03/02/2011 | EP2288603A1 Tetrazole compounds as orexin receptor antagonists |
| 03/02/2011 | EP2288602A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders |
| 03/02/2011 | EP2288601A1 Bicyclylaryl-aryl-amine compounds and their use |
| 03/02/2011 | EP2288594A1 Imidazolidine derivatives |
| 03/02/2011 | EP2207421B1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides |
| 03/02/2011 | EP2190834B1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer |
| 03/02/2011 | EP1957479B1 1,5-substituted indol-2-yl amide derivatives |
| 03/02/2011 | EP1915365B1 Carboxamide compound and use of the same |
| 03/02/2011 | EP1901731B1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/02/2011 | EP1836176B1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF |
| 03/02/2011 | EP1831174B1 Amide derivatives |
| 03/02/2011 | EP1581518B1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 03/02/2011 | EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/02/2011 | EP1383761B1 Phenyl- and pyridyl-piperidines with tnf activity |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN1939916B Compound for treating AIDS |
| 03/02/2011 | CN101983188A Indolinone compound |
| 03/02/2011 | CN101983057A Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
| 03/02/2011 | CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/01/2011 | US7897780 Method for controlling phytopathogenic fungi using silylated carboxamides |
| 03/01/2011 | US7897778 Benzamide compounds |
| 03/01/2011 | US7897775 Crystalline form of a benzimidazole-carboxamide medicinal compound |
| 03/01/2011 | US7897773 Urea derivatives of tropane, their preparation and their therapeutic application |
| 03/01/2011 | US7897772 Acid addition salt of irinotecan |
| 03/01/2011 | US7897765 Therapeutic compounds and uses thereof |
| 03/01/2011 | US7897627 Heteroaryl derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897623 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897614 Preventive agent/remedial agent for constipation predominant IBS |
| 03/01/2011 | US7897611 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 03/01/2011 | US7897603 Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 03/01/2011 | US7897602 Indolinone compounds as kinase inhibitors |
| 03/01/2011 | US7897601 Cannabinoid receptor modulators |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/24/2011 | WO2011022509A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022508A2 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021689A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
| 02/24/2011 | WO2011021000A2 A process for the synthesis of naratriptan |
| 02/24/2011 | WO2011020886A1 Novel quinoline-hepcidine antagonists |
| 02/24/2011 | WO2011020564A1 Novel method for producing 4-aminobut-2-enolides |
| 02/24/2011 | WO2011020288A1 Substituted hydrazide compounds and application thereof |
| 02/24/2011 | WO2011020189A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | WO2010048477A3 Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates |
| 02/24/2011 | WO2008130863A3 Substituted benzimidazoles |
| 02/24/2011 | US20110046384 Process for preparation of e-isomer of 1-(4-methylphenyl) - 1-(2-pyrid yl)-3-pyrrolidino prop-1-ene and acid addition salts thereof |
| 02/24/2011 | US20110046383 Crystalline s-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
| 02/24/2011 | US20110046378 Novel Imaging Agents for Detecting Neurological Dysfunction |
| 02/24/2011 | US20110046376 Methods for synthesizing heterocyclic compounds. |
| 02/24/2011 | US20110046370 1,3,6-substituted indole derivatives having inhibitory activity for protein kinase |
| 02/24/2011 | US20110046186 1-Substituted Pyridyl-Pyrazolyl Amide Compounds and Uses Thereof |
| 02/24/2011 | US20110046185 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 02/24/2011 | US20110046184 Solid state forms of racemic ilaprazole |
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046159 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 02/24/2011 | US20110046152 Amide Compounds, Preparation Methods and Uses Thereof |
| 02/24/2011 | US20110046151 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110046143 Disubstituted phthalazine hedgehog pathway antagonists |
| 02/24/2011 | US20110046137 Pyrazole Derivatives as P2X7 Modulators |
| 02/24/2011 | US20110046135 New compounds i |
| 02/24/2011 | US20110046133 Organic compounds |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/24/2011 | US20110046106 Aryl sulfonamides as effective analgesics |
| 02/24/2011 | US20110046105 Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof |
| 02/24/2011 | US20110046104 Aminopyrimidines useful as kinase inhibitors |
| 02/24/2011 | US20110046088 Iminipyridine derivatives and their uses as microbiocides |
| 02/24/2011 | US20110045608 Imatinib Immunoassay |
| 02/24/2011 | US20110045597 Chemical sensors of zinc, nickel, and copper ions |
| 02/24/2011 | US20110045516 Kits Pertaining to Analyte Determination |
| 02/24/2011 | US20110045101 Fungicidal substituted azoles |
| 02/24/2011 | US20110045100 Antimalarial Quinolines and Methods of Use Thereof |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110042654 Organic compound, and organic photoelectric device comprising the same |
| 02/24/2011 | US20110041730 Thermoplastic Composition |